Tikun Olam Cannbit Pharmaceuticals Ltd Total Liabilities
Tikun Olam Cannbit Pharmaceuticals Ltd total liabilities. Based on the latest financial reports, Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) has total liabilities worth ILA27.50 Million ILA (≈ $73.72K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See defensive interval ratio of Tikun Olam Cannbit Pharmaceuticals Ltd to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Tikun Olam Cannbit Pharmaceuticals Ltd (2017–2024)
Total liabilities of Tikun Olam Cannbit Pharmaceuticals Ltd from 2017 to 2024. This chart illustrates how Tikun Olam Cannbit Pharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data.
Tikun Olam Cannbit Pharmaceuticals Ltd Competitors by Total Liabilities
The table below lists competitors of Tikun Olam Cannbit Pharmaceuticals Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bangkok Sheet Metal Public Company Limited
BK:BM
|
Thailand | ฿938.51 Million |
|
Microbix Biosystems Inc.
TO:MBX
|
Canada | CA$9.80 Million |
|
Juic International
TWO:6114
|
Taiwan | NT$743.66 Million |
|
Nova EYE Medical Ltd
AU:EYE
|
Australia | AU$7.31 Million |
|
Pico (Thailand) Public Company Limited
BK:PICO
|
Thailand | ฿259.55 Million |
|
Aquaron Acquisition Corp. Common Stock
NASDAQ:AQU
|
USA | $5.64 Million |
|
Xbrane Biopharma AB
ST:XBRANE
|
Sweden | Skr103.76 Million |
|
Centric Holdings S.A
AT:CENTR
|
Greece | €11.16 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down Tikun Olam Cannbit Pharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see TKUN asset base.
Liquidity & Leverage Metrics
Tikun Olam Cannbit Pharmaceuticals Ltd Total Liabilities Ratios Explained
Tikun Olam Cannbit Pharmaceuticals Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 3.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tikun Olam Cannbit Pharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tikun Olam Cannbit Pharmaceuticals Ltd (2017–2024)
The table below shows the annual total liabilities of Tikun Olam Cannbit Pharmaceuticals Ltd from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ILA29.36 Million ≈ $78.70K |
-32.56% |
| 2023-12-31 | ILA43.53 Million ≈ $116.70K |
+9.09% |
| 2022-12-31 | ILA39.90 Million ≈ $106.98K |
-13.17% |
| 2021-12-31 | ILA45.96 Million ≈ $123.21K |
-21.78% |
| 2020-12-31 | ILA58.75 Million ≈ $157.51K |
+5.75% |
| 2019-12-31 | ILA55.56 Million ≈ $148.94K |
+692.75% |
| 2018-12-31 | ILA7.01 Million ≈ $18.79K |
+1048.85% |
| 2017-12-31 | ILA610.00K ≈ $1.64K |
-- |
About Tikun Olam Cannbit Pharmaceuticals Ltd
Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers training and patient care services. Tikun Olam-Cannbit Pharmaceuticals Ltd … Read more